1-5 of 5
Maria Elena Zannier
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Novel Gene Mutations Associated with Disease-Free Survival in Elderly Patients with Acute Myeloid Leukemia Receiving First-Line Induction-Consolidation with or without Azacitidine Post-Remission Treatment

Esther Natalie Oliva, Maria Cuzzola, Anna Candoni, Prassede Salutari, Giuseppe Alberto Palumbo, Gianluigi Reda, Giuseppe Ianni', Giovanni Tripepi, Debora Capelli, Caterina Alati, Maria Concetta Cannatà, Pasquale Niscola, Bianca Serio, Santina Barillà, Pellegrino Musto, Ernesto Vigna, Lorella Maria Antonia Melillo, Rocco Tripepi, Ilaria Maria Delfino, Maria Elena Zannier, Yasuhito Nannya, Seishi Ogawa, Corrado Mammì
Journal: Blood
Blood (2023) 142 (Supplement 1): 6046.
https://doi.org/10.1182/blood-2023-186325
Published: 2023
Journal Articles

Intensive Fludarabine, High Dose Cytarabine and Idarubicin-Based Induction for Younger NPM1-Mutated AML Patient: Overcoming the Negative Prognosis of FLT3-ITD Mutation

Paola Minetto, MD PhD, Anna Candoni, Fabio Guolo, MD, Marino Clavio, MD, Maria Elena Zannier, MD, Maurizio Miglino, PhD, Maria Vittoria Dubbini, MD, Anna Sicuranza, PhD, Sara Ciofini, Elisabetta Tedone, Nicoletta Colombo, PhD, Girolamo Pugliese, Filippo Ballerini, MD, Michele Cea, Monica Bocchia, Renato Fanin, MD, Roberto Massimo Lemoli, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 32–33.
https://doi.org/10.1182/blood-2020-142887
Published: 2020
Journal Articles

Addition of the Anti-CD33 Monoclonal Antibody Mylotarg to Fludarabine/High Dose Cytarabine - Based Induction Significantly Improves Outcome in Patient Affected By FLT3-ITD Positive Cytogenetically Normal Acute Myeloid Leukemia

Paola Minetto, MD, Anna Candoni, MD, Fabio Guolo, MD, Marino Clavio, MD, Maria Elena Zannier, MD, Maurizio Miglino, PhD, Maria Vittoria Dubbini, MD, Enrico Carminati, Anna Sicuranza, PhD, Sara Ciofini, Elisabetta Tedone, Paola Contini, Clara Nurra, Monica Passannante, MD, Filippo Ballerini, MD, Antonia Cagnetta, MD, Marco Gobbi, MD, Monica Bocchia, Renato Fanin, MD, Roberto Massimo Lemoli, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1365.
https://doi.org/10.1182/blood-2019-131420
Published: 2019
Journal Articles

Azacitidine for Post-Remission Therapy in Elderly Patients with Acute Myeloid Leukemia : Final Results of the Qoless AZA-Amle Randomized Trial

Esther Natalie Oliva, MD, Anna Candoni, MD, Prassede Salutari, MD, Francesco Di Raimondo, MD, Gianluigi Reda, MD, Debora Capelli, MD, Pasquale Niscola, MD PhD, Carmine Selleri, MD, Pellegrino Musto, MD, Ernesto Vigna, MD, Antonio Volpe, MD, Nicola Cascavilla, Donato Mannina, MD, Paola Carluccio, MD, Maria Elena Zannier, MD, Elisa Mauro, MD, Alessandra Freyrie, MD, Carla Mazzone, MD, Bruno Martino, MD, Caterina Alati, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 117.
https://doi.org/10.1182/blood-2019-125562
Published: 2019
Journal Articles

Fludarabine, High Dose Cytarabine and Idarubicin-Based Induction Is Highly Effective in Young AML Patients with Concomitant NPM1 and FLT3-ITD Mutation Irrespectively of FLT3-ITD Allelic Burden

Paola Minetto, MD, Anna Candoni, MD, Fabio Guolo, MD, Marino Clavio, MD, Maria Elena Zannier, MD, Maurizio Miglino, PhD, Maria Vittoria Dubbini, MD, Enrico Carminati, Anna Sicuranza, PhD, Sara Ciofini, Elisabetta Tedone, Nicoletta Colombo, PhD, Girolamo Pugliese, Riccardo Marcolin, MD, Filippo Ballerini, MD, Michele Cea, Marco Gobbi, MD, Monica Bocchia, Renato Fanin, MD, Roberto Massimo Lemoli, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3828.
https://doi.org/10.1182/blood-2019-131303
Published: 2019